EUVIMEDEUVIMED entdecken
Metaanalyse

RE: SHBG as a breast cancer risk biomarker in premenopausal women? Results from an individual patient's pooled analysis and a meta-analysis

Kefah Mokbel, Kinan Mokbel

JNCI: Journal of the National Cancer Institute · 14.11.2026

DOI: 10.1093/jnci/djag433 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift JNCI: Journal of the National Cancer Institute, online erschienen am 14.11.2026. Verfasst von Kefah Mokbel und 1 weiteren Autor:innen. Beteiligte Einrichtung: Chair of Oncoplastic Breast Surgery, The London Breast Institute, The Princess Grace Hospital, London, UK.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Serrano et al. report that SHBG above the lowest tertile was associated with fewer subsequent breast events among premenopausal women in two low-dose tamoxifen trials (HR 0.60; 95%CI 0.38-0.96).Their meta-analysis found a non-significant association (SOR 0.92; 95%CI 0.78-1.09),which they suggest may reflect limited power (1).Its composition may offer another explanation.The stated inclusion criteria specify studies reporting estimates in healthy premenopausal women, yet the quantitative synthesis includes S007 and TAM01, described as high-risk trial cohorts, alongside generalpopulation studies.We reconstructed study-level estimates from the published forest plot.Because these

Autor:innen und Institutionen

  • Chair of Oncoplastic Breast Surgery, The London Breast Institute, The Princess Grace Hospital, London, UK.
  • Department of Health and Care Professions, Faculty of Health and Life Sciences, University of Exeter, Exeter, UK.

Zitieren

APA

Mokbel, K., & Mokbel, K. (2026). RE: SHBG as a breast cancer risk biomarker in premenopausal women? Results from an individual patient's pooled analysis and a meta-analysis. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djag433

Vancouver

Mokbel K, Mokbel K. RE: SHBG as a breast cancer risk biomarker in premenopausal women? Results from an individual patient's pooled analysis and a meta-analysis. JNCI: Journal of the National Cancer Institute. 2026. doi:10.1093/jnci/djag433

BibTeX
@article{Mokbel2026,
  author = {Mokbel, Kefah and Mokbel, Kinan},
  title = {RE: SHBG as a breast cancer risk biomarker in premenopausal women? Results from an individual patient's pooled analysis and a meta-analysis},
  journal = {JNCI: Journal of the National Cancer Institute},
  year = {2026},
  doi = {10.1093/jnci/djag433}
}
Kostenlos starten →